ABCA8 Elevation Predicts the Prognosis and Exerts the Anti-oncogenic Effects on the Malignancy of Non-small Cell Lung Cancer via TCF21-Mediated Inactivation of PI3K/AKT.

MLA

Yu, Xin, et al. “ABCA8 Elevation Predicts the Prognosis and Exerts the Anti-Oncogenic Effects on the Malignancy of Non-Small Cell Lung Cancer via TCF21-Mediated Inactivation of PI3K/AKT.” Molecular Biotechnology, vol. 67, no. 1, Jan. 2025, pp. 226–36. EBSCOhost, https://doi.org/10.1007/s12033-023-00998-3.

APA

Yu, X., Zhou, G., Zhang, M., & Zhang, N. (2025). ABCA8 Elevation Predicts the Prognosis and Exerts the Anti-oncogenic Effects on the Malignancy of Non-small Cell Lung Cancer via TCF21-Mediated Inactivation of PI3K/AKT. Molecular Biotechnology, 67(1), 226–236. https://doi.org/10.1007/s12033-023-00998-3

Chicago

Yu, Xin, Guoqiong Zhou, Ming Zhang, and Nana Zhang. 2025. “ABCA8 Elevation Predicts the Prognosis and Exerts the Anti-Oncogenic Effects on the Malignancy of Non-Small Cell Lung Cancer via TCF21-Mediated Inactivation of PI3K/AKT.” Molecular Biotechnology 67 (1): 226–36. doi:10.1007/s12033-023-00998-3.